LSDF proudly announces awardees for the 2009 Winter commercialization grant competition. The funded studies will focus on validating the commercial merit of novel technologies to prevent catheter-related infections and diagnose the earliest stages of shock. Support for these initiatives comes from - 1. philanthropic funds donated to the LSDF's grant-making activities by Amgen, The Bill & Melinda Gates Foundation, Group Health Cooperative, Microsoft Corp., The Paul G. Allen Family Foundation, Regence BlueShield, and Safeco Insurance Foundation; and 2. Washington's allocation of bonus payments under the Master Tobacco Settlement Agreement (revenues arising from multi-state litigation with tobacco product manufacturers). This is the fifth cohort of grant awardees funded by LSDF.
Philip Fleckman
Kenneth A. Schenkman
Modified: 03/02/10